PT-141 vs Selank

A comprehensive, data-driven comparison of PT-141 (Bremelanotide) and Selank (TP-7). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.

PT-141
FDA Approved
Hypoactive sexual desire disorder (HSDD) in women
Evidence
High
Monthly Cost$800 - $1,200/mo
DosingAs needed
ManufacturerCosette Pharmaceuticals (Covis Pharma)
Selank
Not submitted
Anxiety disorders and cognitive enhancement
Evidence
Moderate
Monthly Cost$40 - $80/mo
DosingDaily

Side-by-Side Comparison

PropertyPT-141
Bremelanotide, Vyleesi
Selank
TP-7
FDA Status
FDA Approved
Not submitted
Category
Sexual Health
Cognitive Enhancement
Primary Use
Hypoactive sexual desire disorder (HSDD) in women
Anxiety disorders and cognitive enhancement
Weight Loss %
N/A
N/A
Monthly Cost
$800 - $1,200/mo
$40 - $80/mo
Administration
Subcutaneous injection
Nasal spray
Typical Dose
1.75mg as needed, at least 45 min before activity
2-3 drops per nostril 2-3x daily
Frequency
As needed
Daily
Mechanism

Melanocortin receptor agonist that activates central nervous system pathways involved in sexual arousal

Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for anxiolytic effects

Common Side Effects
  • Nausea
  • Flushing
  • Injection site reactions
  • Headache
  • +1 more
  • Nasal irritation
  • Mild drowsiness
  • Headache
Serious Side Effects
  • Increases in blood pressure
  • Darkening of skin
  • Severe nausea
  • Unknown long-term effects
  • Limited safety data
Evidence Quality
High
Moderate
Clinical Trial Phase
Approved
N/A

Key Differences

  • 1PT-141 is FDA-approved, while Selank is currently not submitted.
  • 2Selank is generally more affordable ($40 - $80/mo) compared to PT-141 ($800 - $1,200/mo).
  • 3PT-141 is administered via subcutaneous injection, while Selank uses nasal spray.
  • 4PT-141 is dosed as needed, while Selank is daily.
  • 5PT-141 has high-quality evidence, while Selank has moderate-quality evidence.
  • 6They belong to different categories: PT-141 (Sexual Health) vs Selank (Cognitive Enhancement).

Which Is Better For...

PT

PT-141

Those seeking an FDA-approved treatment with established safety data

SE

Selank

More budget-friendly option with lower monthly costs

PT

PT-141

More convenient dosing schedule (as needed)

SE

Selank

Fewer commonly reported side effects

PT

PT-141

Stronger clinical evidence base to support its use

Cost Comparison

PeptideMonthly Cost RangeFDA StatusManufacturer
PT-141$800 - $1,200/mo
FDA Approved
Cosette Pharmaceuticals (Covis Pharma)
Selank$40 - $80/mo
Not submitted
Various research labs

Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.

Frequently Asked Questions

What is the main difference between PT-141 and Selank?

PT-141 works via Melanocortin receptor agonist that activates central nervous system pathways involved in sexual. Selank works via Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for. They differ in FDA approval status, efficacy data, and cost.

How much does PT-141 cost compared to Selank?

PT-141 typically costs $800 - $1,200/mo, while Selank costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.

Are PT-141 and Selank FDA approved?

PT-141 is FDA-approved. Selank is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.

What are the side effects of PT-141 vs Selank?

Common side effects of PT-141 include Nausea, Flushing, Injection site reactions. Common side effects of Selank include Nasal irritation, Mild drowsiness, Headache. Always consult a healthcare provider about potential side effects.

Can I switch from PT-141 to Selank?

Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.

Learn More

PT-141 Full Profile
Hypoactive sexual desire disorder (HSDD) in women

PT-141 (Bremelanotide) is an FDA-approved peptide medication marketed as Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors like Viagra, PT-14...

View Full PT-141 Guide
Selank Full Profile
Anxiety disorders and cognitive enhancement

Selank is a synthetic heptapeptide developed in Russia as an anxiolytic and nootropic agent. It has been shown to reduce anxiety without causing sedation or addiction, while potentially improving memo...

View Full Selank Guide

Other Popular Comparisons

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between PT-141 and Selank should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.